Aminolevulinic acid topical Pregnancy and Breastfeeding Warnings
Brand names: Ameluz, Levulan Kerastick
Medically reviewed by Drugs.com. Last updated on Oct 30, 2023.
Aminolevulinic acid topical Pregnancy Warnings
Animal studies have not shown reproductive toxicity. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug should be given to a pregnant woman only if clearly needed.
US FDA pregnancy category: C
Aminolevulinic acid topical Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
Comments:The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Levulan Kerastick (aminolevulinic acid). Berlex Laboratories. 2001.
- Cerner Multum, Inc. UK Summary of Product Characteristics.
References for breastfeeding information
- Product Information. Levulan Kerastick (aminolevulinic acid). Berlex Laboratories. 2001.
- Cerner Multum, Inc. UK Summary of Product Characteristics.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.